Annette North

2020 - Turning Point Therapeutics

In 2020, Annette North earned a total compensation of $3.1M as Former Executive Vice President and General Counsel at Turning Point Therapeutics, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$230,400
Option Awards$2,434,953
Salary$400,000
Other$11,400
Total$3,076,753

North received $2.4M in option awards, accounting for 79% of the total pay in 2020.

North also received $230.4K in non-equity incentive plan, $400K in salary and $11.4K in other compensation.

Rankings

In 2020, Annette North's compensation ranked 3,774th out of 13,090 executives tracked by ExecPay. In other words, North earned more than 71.2% of executives.

ClassificationRankingPercentile
All
3,774
out of 13,090
71st
Division
Manufacturing
1,496
out of 5,621
73rd
Major group
Chemicals And Allied Products
563
out of 2,254
75th
Industry group
Drugs
486
out of 1,954
75th
Industry
Pharmaceutical Preparations
367
out of 1,459
75th
Source: SEC filing on April 29, 2022.

North's colleagues

We found four more compensation records of executives who worked with Annette North at Turning Point Therapeutics in 2020.

2020

Athena Countouriotis

Turning Point Therapeutics

Chief Executive Officer

2020

Siegfried PHD

Turning Point Therapeutics

Chief Scientific Officer

2020

Yi Larson

Turning Point Therapeutics

Chief Financial Officer

2020

Mohammad Hirmand

Turning Point Therapeutics

Chief Medical Officer

News

In-depth

You may also like